GB0919594D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0919594D0
GB0919594D0 GBGB0919594.2A GB0919594A GB0919594D0 GB 0919594 D0 GB0919594 D0 GB 0919594D0 GB 0919594 A GB0919594 A GB 0919594A GB 0919594 D0 GB0919594 D0 GB 0919594D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0919594.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0919594.2A priority Critical patent/GB0919594D0/en
Publication of GB0919594D0 publication Critical patent/GB0919594D0/en
Priority to PCT/EP2010/066962 priority patent/WO2011054947A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0919594.2A 2009-11-09 2009-11-09 Compounds Ceased GB0919594D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0919594.2A GB0919594D0 (en) 2009-11-09 2009-11-09 Compounds
PCT/EP2010/066962 WO2011054947A1 (en) 2009-11-09 2010-11-08 Thiadiazolidinedioxide p2x7 receptor antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0919594.2A GB0919594D0 (en) 2009-11-09 2009-11-09 Compounds

Publications (1)

Publication Number Publication Date
GB0919594D0 true GB0919594D0 (en) 2009-12-23

Family

ID=41502097

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0919594.2A Ceased GB0919594D0 (en) 2009-11-09 2009-11-09 Compounds

Country Status (2)

Country Link
GB (1) GB0919594D0 (en)
WO (1) WO2011054947A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR087274A1 (en) 2011-07-22 2014-03-12 Actelion Pharmaceuticals Ltd DERIVATIVES OF AMETAS HETEROCICLICAS AS ANTAGONISTAS OF RECEPTORS P2X7
WO2013108227A1 (en) 2012-01-20 2013-07-25 Actelion Pharmaceuticals Ltd Heterocyclic amide derivatives as p2x7 receptor antagonists
AR093921A1 (en) 2012-12-12 2015-06-24 Actelion Pharmaceuticals Ltd DERIVATIVES OF INDOL CARBOXAMIDE AS ANTAGONISTS OF THE P2X7 RECEIVER
EP2935211B1 (en) 2012-12-18 2016-11-09 Actelion Pharmaceuticals Ltd. Indole carboxamide derivatives as p2x7 receptor antagonists
US9388198B2 (en) 2013-01-22 2016-07-12 Actelion Pharmaceuticals Ltd. Heterocyclic amide derivatives as P2X7 receptor antagonists
EP2956135B1 (en) 2013-01-22 2016-11-16 Actelion Pharmaceuticals Ltd. Heterocyclic amide derivatives as p2x7 receptor antagonists
EP3962493A2 (en) 2019-05-03 2022-03-09 Flagship Pioneering Innovations V, Inc. Methods of modulating immune activity/level of irf or sting or of treating cancer, comprising the administration of a sting modulator and/or purinergic receptor modulator or postcellular signaling factor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133434A (en) 1997-04-28 2000-10-17 Glaxo Group Limited Purinergic receptor
SE0300445D0 (en) 2003-02-18 2003-02-18 Astrazeneca Ab New combination
CA2526883A1 (en) 2003-05-29 2004-12-09 Astrazeneca Ab A pharmaceutical composition comprising a p2x7-receptor antagonist and a tumour necrosis factor .alpha.
US20070281931A1 (en) 2003-05-29 2007-12-06 Nigel Boughton-Smith Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate
EP1644041A1 (en) 2003-05-29 2006-04-12 AstraZeneca AB A pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
SE0302488D0 (en) 2003-09-18 2003-09-18 Astrazeneca Ab New combination
EP1763353A1 (en) 2004-06-29 2007-03-21 Warner-Lambert Company LLC COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X<sb>7</sb> RECEPTOR
WO2006083214A1 (en) 2005-02-02 2006-08-10 Astrazeneca Ab Pharmaceutical composition comprising a p2x7 receptor antagonist and a hmg-coa reductase inhibitor
WO2007008157A1 (en) 2005-07-11 2007-01-18 Astrazeneca Ab New combination 2
EP1906960A4 (en) 2005-07-11 2010-03-10 Astrazeneca Ab New combination 1
GB0724625D0 (en) * 2007-12-18 2008-01-30 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
WO2011054947A1 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
IL213992A0 (en) Pro-neurogenic compounds
EP2393493A4 (en) Compounds
IL219248A0 (en) Compounds
GB0907515D0 (en) Compounds
IL213019A0 (en) Azaazulene compounds
GB0914856D0 (en) Compounds
GB0919194D0 (en) Compounds
GB0915892D0 (en) Compounds
GB0922302D0 (en) Compounds
GB0909671D0 (en) Compounds
ZA201200093B (en) 3-phenoxymethylpyrrolidine compounds
GB0919594D0 (en) Compounds
GB0915519D0 (en) Ntithrombotic compounds
GB0909672D0 (en) Compounds
AP2909A (en) Pyrazinoisoquinoline Compounds
EP2443115A4 (en) Compounds
GB0905932D0 (en) Compounds
GB0905060D0 (en) Compounds
GB0909912D0 (en) Compounds
GB0910008D0 (en) Compounds
GB0910197D0 (en) Compounds
GB0912238D0 (en) Compounds
GB0913248D0 (en) Compounds
GB0913753D0 (en) Compounds
GB0908942D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)